ANDA 87204, held by Legacy. Crotamiton.
As of Nov 16, 2026, ANDA 87204 (Crotan), held by Legacy, was first approved by FDA on Dec 16, 1981, with 3 approved supplements and 0 published complete response letters.
Pruradik (crotamiton USP 10%) is a scabicidal and antipruritic agent as a lotion for topical use only. Crotamiton is a colorless to slightly yellowish oil, having a faint amine-like odor. It is miscible with alcohol and with methanol. Crotamiton is a mixture of the cis and trans isomers. Its molecular weight is 203. 28. Crotamiton is N-ethyl-N(o-methyl-phenyl) 2-butenamide and its structural formula is: Pruradik lotion contains crotamiton USP 10% (100mg/ml) in a creamy lotion base containing purified water, light mineral oil, propylene glycol, cetearyl alcohol (and) cetearth-20, cetyl alcohol, lanolin, benzyl alcohol, carbomer 971P, sodium hydroxide with citric acid (for pH adjustment).
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 16, 1981 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Crotan10% · lotion;topical | Crotamiton | Rx |
| Mar 10, 2014 | Supplement 6Labeling | Approved | None posted |
| Nov 8, 1994 | Supplement 2Labeling | Approved | None posted |
| Feb 11, 1992 | Supplement 1Labeling | Approved | None posted |
| Dec 16, 1981 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters